يعرض 1 - 2 نتائج من 2 نتيجة بحث عن '"C Greilsamer"', وقت الاستعلام: 0.35s تنقيح النتائج
  1. 1
    Academic Journal
    Randomised, open-label, multicentric phase III trial to evaluate the safety and efficacy of palbociclib in combination with endocrine therapy, guided by ESR1 mutation monitoring in oestrogen receptor-positive, HER2-negative metastatic breast cancer patients: study design of PADA-1

    المؤلفون: C Cheneau, S Barthier, J Lemonnier, Fabrice Andre, C Dubot, L Teixeira, A Escande, T De La Motte Rouge, T Petit, L Arnould, Laurent Arnould, Suzette Delaloge, Jerome Lemonnier, A Marti, L Stefani, F Berger, C Levy, P Barthelemy, S Nguyen, M Gardner, A Lortholary, François-Clément Bidard, J Plaza, L Joly, Thibault de la Motte Rouge, F Andre, I Bièche, C Alleaume, R Sabatier, B Lucas, Ivan Bieche, O Derbel, L Venat-Bouvet, F Del Piano, Florian Clatot, Anne-Claire Hardy-Bessard, Frédérique Berger, Margaux Marce, Thomas Bachelot, Anne Pradines, Jean-Luc Canon, Sandrine Marques, M Achille, H Ammarguellat, O Arsene, T Bachelot, C Bernard-Marty, F-C Bidard, N Bonichon-Lamichhane, N Bonnin, R Bouaita, A Boudrant, V-A Brunel, C Chakiba, F Clatot, F Dalenc, A De Gramont, L Deiana, C Delbaldo, V Delecroix, H Desclos, V D'Hondt, N Dohollou, J-M Ferrero, C Foa, J-S Frenel, C Garnier Tixidre, D Genet, O Gisserot, M Gozy, C Greilsamer, J Grenier, F Guinet, A-C Hardy-Bessard, J-P Jacquin, E Lachaier, S Ladoire, A-P Laurenty, R Le Scodan, N Leduc, E Legouffe, C Levache, F Lorchel, N Marques, J Medioni, A Melis, D Mille, D Mollon, L Moreau, I Moullet, M-A Mouret-Reynier, A Najem, H Orfeuvre, J-F Paitel, B Pistilli, C Riedl, P Soulie, D Spaeth, F Trouboul, C Valmar, H Vegas, A Zannetti, FC Bidard, S Delaloge, A Pradines, JL Canon, S Marques

    المصدر: BMJ Open, Vol 12, Iss 3 (2022)

    مصطلحات موضوعية: Medicine

    وصف الملف: electronic resource

    Relation: https://bmjopen.bmj.com/content/12/3/e055821.full; https://doaj.org/toc/2044-6055

    URL الوصول: https://doaj.org/article/8faf6bbc845f4ceeb90674dd08e198da

    View record in DOAJ Full Text Finder

    أضف إلى المفضلة
  2. 2
    304P ESR1 mutations and outcomes in BRCA1/2 or PALB2 germline mutation carriers receiving first line aromatase inhibitor + palbociclib (AI+P) for metastatic breast cancer (MBC) in the PADA-1 trial

    المؤلفون: F-C Bidard, Anne Pradines, Suzette Delaloge, Delphine Loirat, Valérie Delecroix, S. Nguyen, M-A Mouret-Reynier, Thomas Bachelot, C. Greilsamer, J-S. Frenel, Jérôme Lemonnier, C. Levy, A-C. Hardy-Bessard, T. de La Motte Rouge, Florence Dalenc, N. Bonichon-Lamichhane, Frédérique Berger, Barbara Pistilli, Sibille Everhard, Céline Callens

    المصدر: Annals of Oncology. 31:S364

    مصطلحات موضوعية: Aromatase inhibitor, business.industry, medicine.drug_class, First line, PALB2, Hematology, Palbociclib, medicine.disease, Metastatic breast cancer, Germline mutation, Oncology, Cancer research, Medicine, business, Estrogen receptor alpha

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::8f67baf9d6f23c6305b46fa92a5c40ff
    https://doi.org/10.1016/j.annonc.2020.08.406

    View record in OpenAIRE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء